R Squared’s Lexicon Pharmaceuticals LXRX Stock Holding History

R Squared’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105K	Buy	67,526 +20,947	+45%	+$30.5K	0.06%	361
2025 Q4	$53.6K	Buy	46,579 +14,530	+45%	+$20K	0.03%	453
2025 Q3	$43.3K	Buy	32,049 +2,490	+8%	+$2.83K	0.02%	500
2025 Q2	$28K	Buy	+29,559	New	+$19.2K	0.02%	428
2025 Q1	–	Sell	-3,040	Closed	-$2.25K	–	967
2024 Q4	$2.25K	Buy	+3,040	New	+$3.66K	﹤0.01%	1449

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

R Squared's LXRX Position: Q1 2026 in Review

R Squared increased its Lexicon Pharmaceuticals (LXRX) stake by 45% in Q1 2026, buying an estimated $30.5K and bringing the position to 67,526 shares worth $105K. The position accounts for 0.06% of the portfolio, ranked #361.

R Squared first reported a position in LXRX in Q4 2024 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

R Squared held 67,526 shares of Lexicon Pharmaceuticals worth $105K as of Q1 2026.
R Squared bought 20,947 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $30.5K.
Lexicon Pharmaceuticals made up 0.06% of R Squared's portfolio in Q1 2026, its #361 holding.
R Squared first reported a position in Lexicon Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.